Last update:

Allergy and immunology news

In Cordoba, the grass pollen season has grown longer over the last 23 years

A study analyzes the relationship between pollen and meteorological data spanning 23 years, verifying how the wind impacts each phase of the pollen season differently, thereby helping to manage and prevent allergy seasons. ...

Why visceral fat triggers diabetes: Study points to loss of protective macrophages

Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes—by boosting a special type of "good" immune cell in fat tissue.

Rallying more T-cells to immunotherapy's fight against cancer

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't respond to this immunotherapy for reasons not yet fully understood. Australian scientists have found ...

Shining new light on how cytokines manage immune response

Scientists in the Blavatnik Institute at Harvard Medical School and MIT have created a new family of tools that, for the first time, illuminates the missing half of how the immune system uses molecules called cytokines to ...

Certain immune cell subtypes drive lupus, study finds

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by Weill Cornell Medicine ...

Lupus may be triggered by a common virus: New research

About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, including tiredness, fever, joint pain and a characteristic butterfly-shaped rash across the cheeks ...

Are peanut allergies actually declining?

Peanut allergy is one of the most common food allergies, affecting between 1% and 2% of people living in the West. And, for many years, their prevalence has been rising.

How COVID-19 variants outsmart the immune system

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations ...